Comparison of Quality of Life in Chronic Liver Disease Patients Based on Indonesian Version of SF-36 Questionnaire
), Sofia Nuri(2), Nadia Alfiani Jauza(3), Sri Lestari F(4), Rama Tiar Nugroho(5), Chetan Ramesh Kalal(6),
(1) Division of Gastroentero-hepatology, Department of Internal Medicine, Faculty of Medicine, Brawijaya University/ Dr. Saiful Anwar General Hospital, Malang
(2) Internal Medicine Department, Faculty of Medicine, Saiful Anwar General Hospital, Malang, Indonesia, Universitas Brawijaya
(3) Internal Medicine Department, Faculty of Medicine, Saiful Anwar General Hospital, Malang, Indonesia, Universitas Brawijaya
(4) Internal Medicine Department, Faculty of Medicine, Saiful Anwar General Hospital, Malang, Indonesia, Universitas Brawijaya
(5) Internal Medicine Department, Faculty of Medicine, Saiful Anwar General Hospital, Malang, Indonesia, Universitas Brawijaya
(6) Director of Hepatology Department, Glenagles Hospital, Parel, Mumbai, India
Corresponding Author
Abstract
Background: Liver cirrhosis is a chronic progressive disease associated with substantial morbidity and mortality. Although clinical management often emphasizes physical outcomes, assessment of health-related quality of life (HRQoL) provides a more comprehensive evaluation of patient well-being. A validated multidimensional instrument for HRQoL assessment is SF-36 (36-Item Short Form Health Survey). Therefore, this study aims to compare HRQoL among patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC) using Indonesian version of SF-36. There are limited data from Indonesia comparing HRQoL across different stages of chronic liver disease, particularly including patients with chronic hepatitis.
Methods: A cross-sectional study was conducted at Gastroenterohepatology Clinic of Saiful Anwar General Hospital, Malang, using 273 patients including 156 with chronic hepatitis, 88 with liver cirrhosis, and 29 with HCC. HRQoL was assessed using SF-36 questionnaire, which evaluated eight domains. Data were analyzed through Kruskal–Wallis test followed by Mann–Whitney post hoc analysis.
Results: The results showed that HRQoL differed significantly across all SF-36 domains among the three groups (p < 0.001), with the lowest scores observed in patients with HCC. Post hoc analysis showed a progressive decline in quality of life with increasing disease severity. However, no significant difference was found between cirrhosis and HCC groups in role limitations due to emotional problems (p > 0.05).
Conclusion: Advanced stages of chronic liver disease are associated with poorer HRQoL. Emotional role limitations appear less dependent on disease severity, signifying the need for psychological support across all stages.
Keywords
References
Starr SP, Raines D. Cirrhosis: Diagnosis, Management, and Prevention [Internet]. Vol. 84. 2011. Available from: www.aafp.org/afp.
Tapper EB, Parikh ND. Diagnosis and Management of Cirrhosis and Its Complications: A Review. Vol. 329, JAMA. American Medical Association; 2023. p. 1589–602.
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Vol. 79, Journal of Hepatology. Elsevier B.V.; 2023. p. 516–37.
Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, et al. Health related quality of life in people with advanced chronic liver disease. Vol. 61, Journal of Hepatology. Elsevier B.V.; 2014. p. 1158–65.
Lam CLK. Subjective quality of life measures - general principles and concepts. Handbook of disease burdens and quality of life measures. Preedy V.R., Watson R.R. (ed): Springer , New York; 2010. 381-399.
Janani, K., Jain, M., Vargese, J., Srinivasan, V., Harika, K., Michael, T., & Venkataraman, J. (2018). Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires. Clinical and Experimental Hepatology, 4(4), 232–239.
Salim OC, Sudharma NI, Kusumaratna RK, Hidayat A. Validity and reliability of the Indonesian version of the SF-36 quality of life questionnaire in patients with chronic diseases. Med J Indones. 2017;26(3):173–178.
Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., & Collette, L. (2016). Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. The Lancet Oncology, 17(11), e510–e514.
Mustika, S., Susanto, J. P., & Lesmana, C. R. A. (2023). Association between the severity of liver cirrhosis with quality of life and its impact on clinical practice. Egyptian Liver Journal, 13(1), 66.
Kang D, Shim S, Cho J, Lim HK. Systematic review of studies assessing the health-related quality of life of hepatocellular carcinoma patients from 2009 to 2018. Korean Journal of Radiology. 2020 Apr 22;21(6):633.
Xiao S, Xie W, Zhang Y, Lei L, Pan Y. Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019. Annals of Medicine. 2023 Dec 12;55(2):2252326.
Thiele M, Askgaard G, Timm HB, Hamberg O, Gluud LL. Predictors of health‐related quality of life in outpatients with cirrhosis: results from a prospective cohort. Hepatitis research and treatment. 2013;2013(1):479639.
Supriyadi D, et al. Sociocultural perspectives on QoL in Indonesian liver patients. Indonesian J Gastroenterol. 2022;23(1):15–22.
Yulianti M, et al. SF-36 validation in Indonesian population with liver disease. Med J Indonesia. 2021;30(3):221–27.
Siburian R, Chang M. Quality of Life in Patients with Chronic Liver Disease in Jakarta Based on SF-36. J Keperawatan Indonesia. 2020;23(1):35–44.
Peng J., Hepgul N. Symptom Prevalence and Quality of Life of Patients with End-Stage Liver Disease : A Systematic Review And Meta-Analysis. Palliative Medicine. 2018; 33(1) : 24-36. https://doi.org/10.1177/0269216318807051
Huang X., Liu X., et all. Depression and Chronic Liver Diseases : are There Shared Underlying Mechanism. Frontiers in molecular neuroscience. 2017
Article Metrics
Abstract View
: 76 times
Download : 31 times
DOI: 10.24871/2632025255-262
Refbacks
- There are currently no refbacks.
